Efficacy and Safety of Erlotinib Monotherapy for Japanese Patients with Advanced Non-small Cell Lung Cancer: A Phase II Study

Details 詳細情報について

• CRID

  1362262945874453120

• DOI

  10.1097/jto.0b013e31818d6702

• ISSN

  15560864

  http://id.crossref.org/issn/15561380

• Web Site

  https://api.elsevier.com/content/article/PII:S1556086415324783?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1556086415324783?httpAccept=text/plain

• Data Source

  • Crossref